Generation Bio Co. (GBIO)
USD 1.02
(-6.42%)
USD 1.02
(-6.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.9 Million | - | - | - | - | 36 Thousand |
| Cost of Revenue | 79.81 Million | 5.13 Million | 4.53 Million | 3.43 Million | 1.86 Million | - |
| Gross Profit | -73.91 Million | -5.13 Million | -4.53 Million | -3.43 Million | -1.86 Million | 36 Thousand |
| Operating Expenses | 144.46 Million | 141.18 Million | 119.1 Million | 81.11 Million | 62.3 Million | 37.33 Million |
| Selling, General and Administrative Expenses | 50.85 Million | 44.46 Million | 33.85 Million | 22.58 Million | 12.16 Million | 9.17 Million |
| Research and Development Expenses | 93.61 Million | 96.71 Million | 85.24 Million | 58.53 Million | 50.13 Million | 28.15 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 144.46 Million | 141.18 Million | 119.1 Million | 81.11 Million | 62.3 Million | 37.33 Million |
| Operating Income | -138.56 Million | -141.18 Million | -119.1 Million | -81.11 Million | -62.3 Million | -37.29 Million |
| Interest Expense | - | 4.54 Million | 50 Thousand | 591 Thousand | - | - |
| Income Tax Expense | - | -4.54 Million | -4.48 Million | -4.02 Million | -985 Thousand | 1.49 Million |
| Earnings before Tax | -126.61 Million | -136.63 Million | -119.15 Million | -80.52 Million | -61.31 Million | -35.8 Million |
| Net Income | -126.61 Million | -132.09 Million | -114.66 Million | -76.5 Million | -60.33 Million | -35.8 Million |
| Earnings Per Share Basic | -1.96 | -2.27 | -2.04 | -2.81 | -1.31 | -1.82 |
| Earnings Per Share Diluted | -1.96 | -2.27 | -2.04 | -2.81 | -1.31 | -1.82 |
| Weighted Average Shares Outstanding | 64.48 Million | 58.11 Million | 56.29 Million | 27.25 Million | 46.21 Million | 19.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.48 Million | 58.11 Million | 56.29 Million | 27.25 Million | 46.21 Million | 19.69 Million |
| Gross Margin | -12.52 | - | - | - | - | 1.00 |
| EBIT Margin | -22.58 | - | - | - | - | -1026.31 |
| Profit Margin | -21.45 | - | - | - | - | -994.53 |
| EBITDA | -133.3 Million | -136.05 Million | -114.56 Million | -77.68 Million | -60.43 Million | -36.94 Million |
| Earnings Before Tax Margin | -23.47 | - | - | - | - | -1035.94 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.09 Million | 4.05 Million | 5.9 Million | 2.87 Million | 2.14 Million | 880 Thousand |
| Cost of Revenue | 1.26 Million | 1.31 Million | 5.26 Million | 1.96 Million | 1.29 Million | 1.31 Million |
| Gross Profit | 2.82 Million | 2.74 Million | 641 Thousand | 912 Thousand | 853 Thousand | -435 Thousand |
| Operating Expenses | 24.54 Million | 23.14 Million | 144.46 Million | 41.29 Million | 33.5 Million | 34.79 Million |
| Selling, General and Administrative Expenses | 9.41 Million | 10.11 Million | - | 13.37 Million | 11.64 Million | 12.96 Million |
| Research and Development Expenses | 15.12 Million | 13.02 Million | - | 27.92 Million | 21.86 Million | 21.83 Million |
| Other Expenses | 1.49 Million | 56.93 Million | - | - | - | - |
| Cost and Expenses | 25.8 Million | 24.45 Million | 144.46 Million | 41.29 Million | 33.5 Million | 34.79 Million |
| Operating Income | -21.71 Million | -20.39 Million | -138.56 Million | -38.42 Million | -31.35 Million | -33.91 Million |
| Interest Expense | - | - | 11.95 Million | 16.05 Million | - | - |
| Income Tax Expense | - | 1.26 Million | 5.09 Million | 5.39 Million | -1.29 Million | 1.19 Million |
| Earnings before Tax | -20.43 Million | -74.54 Million | -126.61 Million | -35.18 Million | -28.26 Million | -31.06 Million |
| Net Income | -20.43 Million | -74.54 Million | -126.61 Million | -35.18 Million | -28.26 Million | -31.06 Million |
| Earnings Per Share Basic | -0.31 | -1.12 | - | -0.53 | -0.43 | -0.47 |
| Earnings Per Share Diluted | -0.31 | -1.12 | - | -0.53 | -0.43 | -0.47 |
| Weighted Average Shares Outstanding | 66.53 Million | 66.43 Million | 64.48 Million | 66.06 Million | 65.9 Million | 65.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 66.53 Million | 66.43 Million | 64.48 Million | 66.06 Million | 65.9 Million | 65.65 Million |
| Gross Margin | 0.69 | 0.68 | 0.11 | 0.32 | 0.40 | -0.49 |
| EBIT Margin | -5.00 | -4.70 | - | -12.89 | -14.61 | -37.05 |
| Profit Margin | -4.99 | -18.36 | -21.45 | -12.23 | -13.17 | -35.30 |
| EBITDA | -20.44 Million | -19.08 Million | - | -37.09 Million | -31.35 Million | -32.6 Million |
| Earnings Before Tax Margin | -5.31 | -5.02 | -23.47 | -13.35 | -14.61 | -38.54 |
GPTHEALTH
AGRO3
GWO-PN
LOVABLE
UNITECH
NERV